Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Echodyne is a radar technology company that designs and manufactures high-performance, compact, and solid-state radar sensors based on its patented Metamaterial Electronically Scanned Array (MESA) technology. Spun out of Intellectual Ventures and backed by high-profile investors including Bill Gates and Northrop Grumman, the company provides radar solutions for defense, security, and autonomous machine applications such as drones (UAS), counter-UAS, and autonomous vehicles. While its primary markets are defense and security, Echodyne's high-fidelity radar technology has potential applications in healthcare for non-contact vital sign monitoring and patient safety. The company's software-defined radars offer phased-array performance at commercial price points, enabling advanced situational awareness in all weather conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Echodyne.